Jae-Hyoung Song
Overview
Explore the profile of Jae-Hyoung Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song J, Mun S, Mishra S, Kim S, Yang H, Choi S, et al.
Biomol Ther (Seoul)
. 2025 Feb;
33(2):388-398.
PMID: 39979015
Human rhinovirus (HRV) causes the common cold and exacerbates chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease. Despite its significant impact on public health, there are currently...
2.
Lee J, Song J, Mun S, Ko H, Um S, Kim S
Mar Drugs
. 2024 Dec;
22(12).
PMID: 39728099
Four previously undescribed pentacyclic triterpenoid saponins, pannosides F-I (-), were isolated from the halophyte L. (), and their chemical structures were elucidated using 1D and 2D NMR spectroscopy and mass...
3.
Song J, Mun S, Yang H, Kwon Y, Kim S, Song M, et al.
Viruses
. 2024 Jan;
16(1).
PMID: 38275951
Enterovirus A71 (EV71), coxsackievirus A16 (CVA16), and coxsackievirus B3 (CVB3) are pathogenic members of the family that cause a range of diseases, including severe central nervous system complications, myocarditis, and...
4.
Yi E, Kim Y, Song J, Ko H, Ahn S, Lee H, et al.
Vaccine
. 2023 Aug;
41(41):6055-6063.
PMID: 37648607
Hand, foot, and mouth disease (HFMD) is a highly contagious viral infection that is mainly caused by enterovirus 71 (EV71) and coxsackievirus 16 (CVA16). As there are no specific therapeutics...
5.
Yi E, Kim Y, Song J, Ko H, Chang S
Vaccine
. 2023 Mar;
41(13):2243-2252.
PMID: 36863926
Mucosal surfaces are in contact with the external environment and protect the body from infection by various microbes. To prevent infectious diseases at the first line of defense, the establishment...
6.
Kwon E, Li W, Kim Y, Kim B, Chung H, Go Y, et al.
Acta Pharm Sin B
. 2023 Feb;
13(1):174-191.
PMID: 36815046
The development of drug-resistant influenza and new pathogenic virus strains underscores the need for antiviral therapeutics. Currently, neuraminidase (NA) inhibitors are commonly used antiviral drugs approved by the US Food...
7.
Park S, Xuan Nhiem N, Song J, Oh M, Kim K, Ko H, et al.
Nat Prod Res
. 2022 Jul;
37(6):863-870.
PMID: 35787219
Three new monoterpenoid glycosides (-) and one new flavanol () along with 15 known compounds were isolated from the twig of Sieb. et Zucc. The chemical constituent study of the...
8.
Kim S, Song J, Ahn J, Jeong M, Yang Y, Cho J, et al.
Immune Netw
. 2022 May;
22(2):e19.
PMID: 35573153
Coxsackievirus B3 (CVB3) infection causes acute pancreatitis and myocarditis. However, its pathophysiological mechanism is unclear. Here, we investigated how lipid metabolism is associated with exacerbation of CVB3 pathology using high-fat...
9.
Kim S, Jeong M, Mun S, Cho J, Seo M, Kim H, et al.
Viruses
. 2021 Aug;
13(7).
PMID: 34372556
Influenza viruses cause respiratory infections in humans and animals, which have high morbidity and mortality rates. Although several drugs that inhibit viral neuraminidase are used to treat influenza infections, the...
10.
Hong E, Song J, Kim S, Cho J, Jeong B, Yang H, et al.
Immune Netw
. 2020 Sep;
20(4):e32.
PMID: 32895619
Influenza virus is the major cause of seasonal and pandemic flu. Currently, oseltamivir, a potent and selective inhibitor of neuraminidase of influenza A and B viruses, is the drug of...